drugset / Trial / NCT03290391

Linking Infectious and Narcology Care-Part II

NCT03290391

RandomizedParallel-groupOpen-labelHealth-services research

Summary

This study, "Linking Infectious and Narcology Care - Part II (LINC-II)," will implement and evaluate a multi-faceted intervention (LINC-II), via a two-armed randomized controlled trial among 240 HIV-infected PWID in St. Petersburg. LINC-II, comprised of pharmacological therapy (i.e., rapid access to ART and receipt of naltrexone for opioid use disorder) and 12 months of strengths-based case management, will assess HIV outcomes (e.g., HIV viral load suppression), impact on care systems and cost-effectiveness of the intervention.

Timeline

Start
2018-09-19
Primary completion
2022-04-06
Completion
2022-04-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule Other